Hemodynamic Monitoring Devices Market Size Worth $1.39 Billion by 2026, with Leading Players – LiDCO Group Plc., Drager Medical GmbH, Cheetah Medical and More

April 27 00:15 2021
Hemodynamic Monitoring Devices Market Size Worth $1.39 Billion by 2026, with Leading Players - LiDCO Group Plc., Drager Medical GmbH, Cheetah Medical and More

Hemodynamic Monitoring Devices Market
Increasing cases of critical illness in geriatric patients, high incidence of cardiovascular diseases & diabetes, rise in demand for hemodynamic monitoring devices

The global Hemodynamic Monitoring Devices Market was valued at USD 838.2 million in 2018 and is expected to reach USD 1.39 billion by the year 2026, at a CAGR of 6.2%. The measurement or estimation of hemodynamic variables such as blood pressure, blood flow, cardiac contractility, cardiac preload, and cardiac afterload plays a crucial role in the monitoring and diagnostic procedures especially in the intensive care unit or in case of patients having major surgery. Hemodynamic monitoring devices facilitate the accurate assessment of blood flow from inside the arteries, heart, and veins. Hemodynamic monitoring plays a fundamental role in the management of acutely ill patients. According to the Society of Critical Care Medicine, the annual cost of critical care has significantly increased in recent years. These devices are extensively used in monitoring the critical patient’s post-surgery as well as in many procedures. With increased concerns about the use of invasive techniques, notably the pulmonary artery catheter, to measure cardiac output monitoring can help to identify underlying pathophysiological processes so that appropriate forms of therapy can be selected.

Invasive hemodynamic monitoring is one of the major competencies required for critical care nurses. In clinical routine, it is commonly performed during high-risk surgery and in intensive care medicine. Continuous assessment of the clinical conditions of the cardiovascular system is essential for critically ill patients to diagnose and manage complex medical conditions. According to WHO, 17.9 million people die each year from cardiovascular diseases, which is an estimated 31% of all deaths worldwide. According to data, the cases of cardiovascular diseases are increasing in developing countries, which is expected to boost the market during the forecast period. The increasing digitalization of hospital systems, rise in aging demographics diagnosed with chronic diseases, high incidence of cardiovascular diseases, technological developments, and high level of research and development facilitate the growth of the global hemodynamic monitoring devices market. Moreover, adequate reimbursement, extensive use for post-surgery monitoring of critically ill patients, and increased government focus to improve medical care infrastructure are further anticipated to boost the market during the forecast period.

Request free sample of this research report at : https://www.reportsanddata.com/sample-enquiry-form/2122

Key findings in the report:

  • The global Hemodynamic Monitoring devices market is forecasted to grow with a CAGR of 6.5% due to high incidence of cardiovascular diseases and diabetes
  • The non-invasive type segment is forecasted to register the highest CAGR of 7.2%. Non-invasive systems allow the in-house assessment of hemodynamic statistics without compromising on the accuracy and reliability thereby increasing their demand during the forecast period
  • The invasive segment lead the global hemodynamic monitoring devices market and is expected to be dominant in the upcoming years accounting for a market share of 38.8%. The invasive devices provide accurate and comprehensive data of the patients and hence is preferred the most
  • The disposables segment dominated the market in terms of revenue generation. Furthermore, the monitoring devices market is expected to witness modest growth
  • The hemodynamic monitoring devices are used in Hospitals extensively in a number of surgeries, for accurate monitoring of critically ill patients which drives the Hospital segment growth robustly. The hospital segment is expected to achieve market share of 37.0% during the period of 2019-2026
  • The Asia Pacific region is projected to be the fastest growing regional market with a CAGR of 7.3%. The factors fostering the market growth are Economic development in leading countries of India, China and Japan along with favorable government initiatives towards improving healthcare infrastructure is expected fuel market growth
  • The North America region accounted for the largest market share of the global Hemodynamic Monitoring devices market in 2018 and is estimated to continue its dominance with a share of 3% in terms of revenue generation
  • Tandem Mass Spectrometry segment dominated with a market share of 40.0% in 2018 and is expected to maintain its lead due to its increasing use in combination with liquid chromatography which aids in overcoming challenges associated with traditional techniques in Hemodynamic Monitoring devices
  • Key participants include Edwards Lifesciences Corporation, ICU Medical, Inc., LiDCO Group Plc., Drager Medical GmbH, Cheetah Medical, Hemo Sapiens, Inc., GE Healthcare, Schwarzer Cardiotek GmbH, Teleflex Incorporated, Siemens, Osypka Medical GmbH, PULSION Medical Systems SE, Deltex Medical Group Plc., Tensys Medical, Inc., McKessen, and Philips Medical.

Hemodynamic Monitoring Devices Market Analysis, by Product, By Type, By End Use, Forecasts to 2026, To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/hemodynamic-monitoring-devices-market

For the purpose of this report, Reports and Data has segmented the Hemodynamic Monitoring devices market on the basis of Product type, type, End-use, and region:

Product (Revenue, USD Million; 2016–2026)

  • Monitors                     
  • Disposables

Type (Revenue, USD Million; 2016–2026)

  • Invasive
  • Minimally invasive
  • Non-invasive
    • ECG
    • Blood Pressure
    • Urine Output
    • Thoracic Electrical Bioimpedence
    • Others

End – Use (Revenue, USD Million; 2016–2026)

  • Hospitals
  • Clinics & Ambulatory Care Centres (ACCs)
  • Homecare Settings
  • Others

Order Now: https://www.reportsanddata.com/checkout-form/2122

Regional Outlook (Revenue in USD Billion; 2017–2026)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Egypt
    • Rest of MEA

Table Of Content

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2018 – 2026

Chapter 3. Indicative Metrics

    3.1. Ageing demographics

    3.2. rise in demand for Hemodynamic monitoring devices

    3.3. Global burden of diabetes

    3.4. Increasing digitalization of hospital systems

Chapter 4. Hemodynamic Monitoring devices Segmentation & Impact Analysis

    4.1. Hemodynamic Monitoring devices Segmentation Analysis

    4.2. Hemodynamic Monitoring devices Market Value Chain Analysis, 2016-2026

……………..

Chapter 9. Competitive Landscape

    9.1. Market Revenue Share by Manufacturers

    9.2. Manufacturing Cost Breakdown Analysis

    9.3. Mergers & Acquisitions

    9.4. Strategy Benchmarking

    9.5. Vendor Landscape

Chapter 10. Company Profiles

    10.1. Edwards Lifesciences Corporation

           10.1.1. Company Overview

           10.1.2. Financial Performance

           10.1.3. Product Length Benchmarking

           10.1.4. Strategic Initiatives

    10.2. ICU Medical, Inc

           10.2.1. Company Overview

           10.2.2. Financial Performance

           10.2.3. Product Length Benchmarking

           10.2.4. Strategic Initiatives

   10.3. LiDCO Group Plc

          10.3.1. Company Overview

          10.3.2. Financial Performance

          10.3.3. Product Length Benchmarking

          10.3.4. Strategic Initiatives

    10.4. Drager Medical GmbH

            10.4.1. Company Overview

            10.4.2. Financial Performance

            10.4.3. Product Length Benchmarking

            10.4.4. Strategic Initiatives

    10.5. Cheetah Medical

            10.5.1. Company Overview

            10.5.2. Financial Performance

            10.5.3. Product Length Benchmarking

            10.5.4. Strategic Initiatives

Continue …

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/hemodynamic-monitoring-devices-market


Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/deccansamachar.org/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7